{"id":24550,"date":"2022-11-07T12:18:10","date_gmt":"2022-11-07T16:18:10","guid":{"rendered":"https:\/\/elearning.wfh.org\/resource\/sesion-medica-congreso-mundial-fmh-2022\/"},"modified":"2024-11-13T12:40:07","modified_gmt":"2024-11-13T16:40:07","slug":"sesion-medica-congreso-mundial-fmh-2022","status":"publish","type":"resource","link":"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/","title":{"rendered":"Sesi\u00f3n m\u00e9dica | Congreso Mundial FMH 2022"},"content":{"rendered":"<p class=\"clamp_p\" style=\"margin-bottom: 2em;\">En estas sesiones del Congreso Mundial 2022 de la FMH, escuche Radek Kaczmarek, Johnny Mahlangu, Steve Pipe, K. Rajender Reddy, Pratima Chowdary, Angela Weyand, Johnny Mahlangu, Gili Kenet y Amy Shapiro abordar temas m\u00e9dicos actuales en trastornos de la coagulaci\u00f3n. <\/p>\n<div class=\"alert alert-danger\" style=\"color: #333333!important; border-color: #fedede; background-color: #fdeaea; padding: 1em 1em 1em 4em; position: relative; margin-top: 1em; margin-bottom: 2em!important;\">\n<div style=\"bottom: 0; left: 0; position: absolute; top: 0; width: 4em; color: #ff7877;\">\n<p class=\"fa fa-info-circle\" style=\"left: 50%; top: 50%; position: absolute; transform: translate(-50%, -50%); font-size: 1.7em;\">\n<\/div>\n<p class=\"clamp_p\">La FMH no se compromete en la pr\u00e1ctica de la medicina y en ning\u00fan caso recomienda un tratamiento particular para individuos espec\u00edficos. Para el diagn\u00f3stico o consulta de un problema m\u00e9dico espec\u00edfico, la FMH recomienda que se ponga en contacto con su m\u00e9dico o con el centro de tratamiento local. Antes de administrar cualquier producto, la FMH insta a los pacientes a que comprueben las dosis con un m\u00e9dico o con el personal del centro de hemofilia, y a que consulten las instrucciones impresas de la compa\u00f1\u00eda farmac\u00e9utica.<\/p>\n<p class=\"clamp_p\">La FMH no promueve ning\u00fan producto farmac\u00e9utico en particular y cualquier menci\u00f3n de una marca comercial en esta presentaci\u00f3n es estrictamente con fines educativos.<\/p>\n<\/div>\n<div id=\"accordion\">\n<!--div class=\"card\" style=\"margin-bottom: .5em;\">\n\n\n<div id=\"headingOne\" class=\"card-header\">\n\n\n<h5 class=\"mb-0\"><button class=\"btn btn-link btn-acc\" data-toggle=\"collapse\" data-target=\"#collapseOne\" aria-expanded=\"true\" aria-controls=\"collapseOne\">Big picture initiatives in bleeding disorders<\/button><\/h5>\n\n\n<\/div>\n\n\n\n\n<div id=\"collapseOne\" class=\"collapse\" aria-labelledby=\"headingOne\" data-parent=\"#accordion\">\n\n\n<div class=\"card-body\">\n\n\n<p class=\"\">In this session from the WFH 2022 World Congress, David Lillicrap (Canada), Len Valentino (United States), Sophie Susen (France) and Mrinal Gounder (United States) discuss that there has been significant advances and improvement in the lives of persons with a bleeding disorder. However, there is still much more to be accomplished for the underserved populations. The session will examine 3 important initiatives for the bleeding disorder community: NHF national research blueprint; Principles of care for management of women with bleeding disorders; and brining cures to von Willebrand disease.<\/p>\n\n\n\n\n\n<div style=\"margin-top: 1em; padding: 56.25% 0 0 0; position: relative;\"><iframe style=\"position: absolute; top: 0; left: 0; width: 100%; height: 100%; border: 1px solid #d8d8d8;\" src=\"https:\/\/player.vimeo.com\/video\/708666047?h=e2e4636ce7&byline=0&portrait=0\" width=\"640\" height=\"360\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n\n\n<\/div>\n\n\n<\/div>\n\n\n<\/div-->\n<p><!--div class=\"card\" style=\"margin-bottom: .5em;\">\n\n\n<div id=\"headingTwo\" class=\"card-header\">\n\n\n<h5 class=\"mb-0\"><button class=\"btn btn-link btn-acc collapsed\" data-toggle=\"collapse\" data-target=\"#collapseTwo\" aria-expanded=\"false\" aria-controls=\"collapseTwo\">Comorbidities<\/button><\/h5>\n\n\n<\/div>\n\n\n\n\n<div id=\"collapseTwo\" class=\"collapse\" aria-labelledby=\"headingTwo\" data-parent=\"#accordion\">\n\n\n<div class=\"card-body\">\n\n\n<p class=\"\">In this session from the WFH 2022 World Congress, Rebecca Kruse-Jarres (United States), Christine Mrakotsky (United States), Roger Schutgens (Netherlands) and Dan Hart (United Kingdom) discuss cognitive and behavioral outcomes in children and young adults with hemophilia, updates from the eTHINK study; cardiovascular disease; and inhibitors in severe and mild hemophilia.<\/p>\n\n\n\n\n\n<div style=\"margin-top: 1em; padding: 56.25% 0 0 0; position: relative;\"><iframe style=\"position: absolute; top: 0; left: 0; width: 100%; height: 100%; border: 1px solid #d8d8d8;\" src=\"https:\/\/player.vimeo.com\/video\/708668791?h=57f8bf2dd6&byline=0&portrait=0\" width=\"640\" height=\"360\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n\n\n<\/div>\n\n\n<\/div>\n\n\n<\/div-->\n<p><!--div class=\"card\" style=\"margin-bottom: .5em;\">\n\n\n<div id=\"headingThree\" class=\"card-header\">\n\n\n<h5 class=\"mb-0\"><button class=\"btn btn-link btn-acc collapsed\" data-toggle=\"collapse\" data-target=\"#collapseThree\" aria-expanded=\"false\" aria-controls=\"collapseThree\">Diagnosis of rare bleeding disorders<\/button><\/h5>\n\n\n<\/div>\n\n\n\n\n<div id=\"collapseThree\" class=\"collapse\" aria-labelledby=\"headingThree\" data-parent=\"#accordion\">\n\n\n<div class=\"card-body\">\n\n\n<p class=\"\">In this session from the WFH 2022 World Congress, Margaret Rand (Canada), Karina Meijer (Netherlands), Waander van Heerde (Netherlands) and Keith Gomez (United Kingdom) discuss application of novel therapeutics for rare bleeding disorders, current lab diagnostic workflow and next generation sequencing approaches.<\/p>\n\n\n\n\n\n<div style=\"margin-top: 1em; padding: 56.25% 0 0 0; position: relative;\"><iframe style=\"position: absolute; top: 0; left: 0; width: 100%; height: 100%; border: 1px solid #d8d8d8;\" src=\"https:\/\/player.vimeo.com\/video\/710907815?h=451bc17de4&byline=0&portrait=0\" width=\"640\" height=\"360\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n\n\n<\/div>\n\n\n<\/div>\n\n\n<\/div-->\n<p><!--div class=\"card\" style=\"margin-bottom: .5em;\">\n\n\n<div id=\"headingFour\" class=\"card-header\">\n\n\n<h5 class=\"mb-0\"><button class=\"btn btn-link btn-acc collapsed\" data-toggle=\"collapse\" data-target=\"#collapseFour\" aria-expanded=\"false\" aria-controls=\"collapseFour\">Free paper session - Clinical research<\/button><\/h5>\n\n\n<\/div>\n\n\n\n\n<div id=\"collapseFour\" class=\"collapse\" aria-labelledby=\"headingFour\" data-parent=\"#accordion\">\n\n\n<div class=\"card-body\">\n\n\n<p class=\"\">In this session from the WFH 2022 World Congress, Emna Gouider (Tunisia), Charles Nakar (United States), Brian R. Long (United States), Tiago Lopes (Japan) and Claire Pouplard (France) present their highly scored abstracts on clinical research and clinical trials.<\/p>\n\n\n\n\n\n<div style=\"margin-top: 1em; padding: 56.25% 0 0 0; position: relative;\"><iframe style=\"position: absolute; top: 0; left: 0; width: 100%; height: 100%; border: 1px solid #d8d8d8;\" src=\"https:\/\/player.vimeo.com\/video\/710960792?h=5d7479f6b8&byline=0&portrait=0\" width=\"640\" height=\"360\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n\n\n<\/div>\n\n\n<\/div>\n\n\n<\/div-->\n<div class=\"card\" style=\"margin-bottom: .5em;\">\n<div id=\"headingFive\" class=\"card-header\">\n<h5 class=\"mb-0\"><button class=\"btn btn-link btn-acc collapsed\" data-toggle=\"collapse\" data-target=\"#collapseFive\" aria-expanded=\"false\" aria-controls=\"collapseFive\">Terapia g\u00e9nica: \u00bfya estamos listos?<\/button><\/h5>\n<\/div>\n<div id=\"collapseFive\" class=\"collapse\" aria-labelledby=\"headingFive\" data-parent=\"#accordion\">\n<div class=\"card-body\">\n<p class=\"\">En esta sesi\u00f3n plenaria del Congreso Mundial 2022 de la FMH, Radek Kaczmarek (Polonia) analiza la investigaci\u00f3n de fase 3, as\u00ed como el seguimiento multianual en estudios de fase previa, que generaron inquietudes con respecto a la eficacia y la seguridad a corto plazo y largo plazo, lo que dio lugar a que se reconsiderase la terapia g\u00e9nica del vector AAV. La toxicidad hep\u00e1tica, si bien suele ser leve, se presenta, por lo menos, en algunos pacientes en todos los ensayos de hemofilia A y B dentro del primer a\u00f1o y no se conoce mucho al respecto.  La seguridad a largo plazo requerir\u00e1 un seguimiento de por vida.  En este plenario se examinar\u00e1n las v\u00edas que ser\u00e1n cruciales para desarrollar mitigaciones y soluciones a los problemas restantes, incluidos los de quienes no pueden recibir terapia g\u00e9nica en este momento.<\/p>\n<div style=\"margin-top: 1em; padding: 56.25% 0 0 0; position: relative;\"><iframe style=\"position: absolute; top: 0; left: 0; width: 100%; height: 100%; border: 1px solid #d8d8d8;\" src=\"https:\/\/player.vimeo.com\/video\/711835648?h=ff7ba38fde&#038;byline=0&#038;portrait=0\" width=\"640\" height=\"360\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"card\" style=\"margin-bottom: .5em;\">\n<div id=\"headingSix\" class=\"card-header\">\n<h5 class=\"mb-0\"><button class=\"btn btn-link btn-acc collapsed\" data-toggle=\"collapse\" data-target=\"#collapseSix\" aria-expanded=\"false\" aria-controls=\"collapseSix\">Terapia g\u00e9nica: Aspectos pr\u00e1cticos de la implementaci\u00f3n<\/button><\/h5>\n<\/div>\n<div id=\"collapseSix\" class=\"collapse\" aria-labelledby=\"headingSix\" data-parent=\"#accordion\">\n<div class=\"card-body\">\n<p class=\"\">En esta sesi\u00f3n del Congreso Mundial 2022 de la FMH, Johnny Mahlangu (Sud\u00e1frica), Steve Pipe (Estados Unidos), K. Rajender Reddy (Estados Unidos) y Pratima Chowdary (Reino Unido) debaten aspectos pr\u00e1cticos de implementaci\u00f3n, desde la salud hep\u00e1tica hasta el manejo de la inmunosupresi\u00f3n.<\/p>\n<div style=\"margin-top: 1em; padding: 56.25% 0 0 0; position: relative;\"><iframe style=\"position: absolute; top: 0; left: 0; width: 100%; height: 100%; border: 1px solid #d8d8d8;\" src=\"https:\/\/player.vimeo.com\/video\/711823835?h=9b7ccb0288&#038;byline=0&#038;portrait=0\" width=\"640\" height=\"360\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n<\/div>\n<\/div>\n<\/div>\n<p><!--div class=\"card\" style=\"margin-bottom: .5em;\">\n\n\n<div id=\"headingSeven\" class=\"card-header\">\n\n\n<h5 class=\"mb-0\"><button class=\"btn btn-link btn-acc collapsed\" data-toggle=\"collapse\" data-target=\"#collapseSeven\" aria-expanded=\"false\" aria-controls=\"collapseSeven\">Hemophilia gene therapy: Update on new country initiatives<\/button><\/h5>\n\n\n<\/div>\n\n\n\n\n<div id=\"collapseSeven\" class=\"collapse\" aria-labelledby=\"headingSeven\" data-parent=\"#accordion\">\n\n\n<div class=\"card-body\">\n\n\n<p class=\"\">In this session from the WFH 2022 World Congress, Alok Srivastava (India), Ulrike Reiss (United States), Lei Zhang (China) and Tsukasa Ohmori (Japan) discuss the current efforts in establishing gene therapy for hemophilia A and hemophilia B in selected countries, including Japan, China, India, South Africa, and Brazil, and including the hemophilia gene therapy program for LMIC led by St. Jude Children\u2019s Research Hospital, US, to include Peru, Vietnam, Thailand, Nepal, and Sri Lanka will be presented.<\/p>\n\n\n\n\n\n<div style=\"margin-top: 1em; padding: 56.25% 0 0 0; position: relative;\"><iframe style=\"position: absolute; top: 0; left: 0; width: 100%; height: 100%; border: 1px solid #d8d8d8;\" src=\"https:\/\/player.vimeo.com\/video\/708683558?h=d1709e98db&byline=0&portrait=0\" width=\"640\" height=\"360\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n\n\n<\/div>\n\n\n<\/div>\n\n\n<\/div-->\n<p><!--div class=\"card\" style=\"margin-bottom: .5em;\">\n\n\n<div id=\"headingEight\" class=\"card-header\">\n\n\n<h5 class=\"mb-0\"><button class=\"btn btn-link btn-acc collapsed\" data-toggle=\"collapse\" data-target=\"#collapseEight\" aria-expanded=\"false\" aria-controls=\"collapseEight\">Inhibitors: Diagnostic challenges, unknowns of inhibitor development, treatment of bleeding and surgery, and insights into diagnosis and treatment<\/button><\/h5>\n\n\n<\/div>\n\n\n\n\n<div id=\"collapseEight\" class=\"collapse\" aria-labelledby=\"headingEight\" data-parent=\"#accordion\">\n\n\n<div class=\"card-body\">\n\n\n<p class=\"\">In this session from the WFH 2022 World Congress, Margaret Rand (Canada), Shannon Meeks (United States), Carmen Escuriola (Germany), Renchi Yang (China) and Wenman Wu (China) discuss diagnostic challenges, unknowns of inhibitor development, treatment of bleeding and surgery, and INH incidence and eradication in China.<\/p>\n\n\n\n\n\n<div style=\"margin-top: 1em; padding: 56.25% 0 0 0; position: relative;\"><iframe style=\"position: absolute; top: 0; left: 0; width: 100%; height: 100%; border: 1px solid #d8d8d8;\" src=\"https:\/\/player.vimeo.com\/video\/710859062?h=657b1eebe4&byline=0&portrait=0\" width=\"640\" height=\"360\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n\n\n<\/div>\n\n\n<\/div>\n\n\n<\/div-->\n<p><!--div class=\"card\" style=\"margin-bottom: .5em;\">\n\n\n<div id=\"headingNine\" class=\"card-header\">\n\n\n<h5 class=\"mb-0\"><button class=\"btn btn-link btn-acc collapsed\" data-toggle=\"collapse\" data-target=\"#collapseNine\" aria-expanded=\"false\" aria-controls=\"collapseNine\">Liver disease in bleeding disorders<\/button><\/h5>\n\n\n<\/div>\n\n\n\n\n<div id=\"collapseNine\" class=\"collapse\" aria-labelledby=\"headingNine\" data-parent=\"#accordion\">\n\n\n<div class=\"card-body\">\n\n\n<p class=\"\">In this session from the WFH 2022 World Congress, David Lillicrap (Canada), Heiner Weidemeyer (Germany), Amit Singal (United States) and Graham Foster (United Kingdom) discuss treatment of hepatitis in hemophilia, monitoring for and treating cirrhosis and hepatocellular carcinoma, and the impact of liver health on gene therapy.<\/p>\n\n\n\n\n\n<div style=\"margin-top: 1em; padding: 56.25% 0 0 0; position: relative;\"><iframe style=\"position: absolute; top: 0; left: 0; width: 100%; height: 100%; border: 1px solid #d8d8d8;\" src=\"https:\/\/player.vimeo.com\/video\/711785251?h=bf550b9034&byline=0&portrait=0\" width=\"640\" height=\"360\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n\n\n<\/div>\n\n\n<\/div>\n\n\n<\/div-->\n<p><!--div class=\"card\" style=\"margin-bottom: .5em;\">\n\n\n<div id=\"headingTen\" class=\"card-header\">\n\n\n<h5 class=\"mb-0\"><button class=\"btn btn-link btn-acc collapsed\" data-toggle=\"collapse\" data-target=\"#collapseTen\" aria-expanded=\"false\" aria-controls=\"collapseTen\">Low-dose prophylaxis and antifibrinolytics: options to consider with proven benefits for persons with hemophilia<\/button><\/h5>\n\n\n<\/div>\n\n\n\n\n<div id=\"collapseTen\" class=\"collapse\" aria-labelledby=\"headingTen\" data-parent=\"#accordion\">\n\n\n<div class=\"card-body\">\n\n\n<p class=\"\">In this session from the WFH 2022 World Congress, Alok Srivastava (India), Manuel Carcao (Canada), Runhui Wu (China), Min Zhou (China) and Emna Gouider (Tunisia) discuss how prophylaxis has become standard of care for persons with severe phenotype hemophilia.  However, \u201cstandard prophylaxis\u201d with either factor or non-factor therapies (emicizumab) is prohibitively expensive for much of the world.  The presenters will evaluate whether hemophilia care can be provided at a lower cost yet achieve good results using Lower dose\/Lower frequency prophylaxis and with increasing use of antifibrinolytics (Tranexamic acid and Epsilon amino caproic acid).<\/p>\n\n\n\n\n\n<div style=\"margin-top: 1em; padding: 56.25% 0 0 0; position: relative;\"><iframe style=\"position: absolute; top: 0; left: 0; width: 100%; height: 100%; border: 1px solid #d8d8d8;\" src=\"https:\/\/player.vimeo.com\/video\/708697624?h=b97179b6eb&byline=0&portrait=0\" width=\"640\" height=\"360\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n\n\n<\/div>\n\n\n<\/div>\n\n\n<\/div-->\n<p><!--div class=\"card\" style=\"margin-bottom: .5em;\">\n\n\n<div id=\"heading11\" class=\"card-header\">\n\n\n<h5 class=\"mb-0\"><button class=\"btn btn-link btn-acc collapsed\" data-toggle=\"collapse\" data-target=\"#collapse11\" aria-expanded=\"false\" aria-controls=\"collapse11\">Managing invasive procedures in hemophilia patients with limited resources, extended half-life concentrates or non-replacement therapies in 2022<\/button><\/h5>\n\n\n<\/div>\n\n\n\n\n<div id=\"collapse11\" class=\"collapse\" aria-labelledby=\"heading11\" data-parent=\"#accordion\">\n\n\n<div class=\"card-body\">\n\n\n<p class=\"\">In this session from the WFH 2022 World Congress, Robert Klamroth (Germany), Shashikant Apte (India), Cedric Hermans (Belgium) and Maria Elisa Mancuso (Italy) discuss invasive procedures in patients with hemophilia with limited resources, invasive procedures with extended half-life concentrates, and invasive procedures in the era of non-factor replacement therapy.<\/p>\n\n\n\n\n\n<div style=\"margin-top: 1em; padding: 56.25% 0 0 0; position: relative;\"><iframe style=\"position: absolute; top: 0; left: 0; width: 100%; height: 100%; border: 1px solid #d8d8d8;\" src=\"https:\/\/player.vimeo.com\/video\/710830912?h=3e7ca3fa99&byline=0&portrait=0\" width=\"640\" height=\"360\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n\n\n<\/div>\n\n\n<\/div>\n\n\n<\/div-->\n<div class=\"card\" style=\"margin-bottom: .5em;\">\n<div id=\"heading12\" class=\"card-header\">\n<h5 class=\"mb-0\"><button class=\"btn btn-link btn-acc collapsed\" data-toggle=\"collapse\" data-target=\"#collapse12\" aria-expanded=\"false\" aria-controls=\"collapse12\">Terapia sin factor<\/button><\/h5>\n<\/div>\n<div id=\"collapse12\" class=\"collapse\" aria-labelledby=\"heading12\" data-parent=\"#accordion\">\n<div class=\"card-body\">\n<p class=\"\">En esta sesi\u00f3n del Congreso Mundial 2022 de la FMH, Angela Weyand (Estados Unidos), Julia Chadwick (Canad\u00e1), Alfonso Iorio (Canad\u00e1), Johnny Mahlangu (Sud\u00e1frica) y Gili Kenet (Israel) analizan la terapia sin factor, con inclusi\u00f3n de la administraci\u00f3n de emicizumab basada en la farmacocin\u00e9tica, la implantaci\u00f3n de emicizumab, y los ensayos cl\u00ednicos en lactantes y la recurrencia de inhibidores y reg\u00edmenes de inducci\u00f3n de la inmunotolerancia (ITI por su sigla en ingl\u00e9s) y anticuerpos antif\u00e1rmacos.<\/p>\n<div style=\"margin-top: 1em; padding: 56.25% 0 0 0; position: relative;\"><iframe style=\"position: absolute; top: 0; left: 0; width: 100%; height: 100%; border: 1px solid #d8d8d8;\" src=\"https:\/\/player.vimeo.com\/video\/712203148?h=b590b5045f&#038;byline=0&#038;portrait=0\" width=\"640\" height=\"360\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"card\" style=\"margin-bottom: .5em;\">\n<div id=\"heading13\" class=\"card-header\">\n<h5 class=\"mb-0\"><button class=\"btn btn-link btn-acc collapsed\" data-toggle=\"collapse\" data-target=\"#collapse13\" aria-expanded=\"false\" aria-controls=\"collapse13\">Avances terap\u00e9uticos y tecnol\u00f3gicos en la atenci\u00f3n de la hemofilia<\/button><\/h5>\n<\/div>\n<div id=\"collapse13\" class=\"collapse\" aria-labelledby=\"heading13\" data-parent=\"#accordion\">\n<div class=\"card-body\">\n<p class=\"\">En esta sesi\u00f3n plenaria del Congreso Mundial 2022 de la FMH, Amy Shapiro (Estados Unidos) analiza los avances de gran alcance en el tratamiento de la hemofilia y en las innovaciones en el manejo que, en conjunto, respaldan una mejora de resultados y calidad de vida para todos los que viven con trastornos de la coagulaci\u00f3n. En esta sesi\u00f3n plenaria se estudiar\u00e1n los desaf\u00edos y estrategias para profesionales de la salud en cuanto al manejo de estas nuevas terapias con y sin factor, as\u00ed como los avances tecnol\u00f3gicos en la atenci\u00f3n de personas con trastornos de la coagulaci\u00f3n.<\/p>\n<div style=\"margin-top: 1em; padding: 56.25% 0 0 0; position: relative;\"><iframe style=\"position: absolute; top: 0; left: 0; width: 100%; height: 100%; border: 1px solid #d8d8d8;\" src=\"https:\/\/player.vimeo.com\/video\/712291691?h=eaac3ed233&#038;byline=0&#038;portrait=0\" width=\"640\" height=\"360\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<style>.btn-acc {background:#f7f7f7!important; box-shadow: none!important;text-align:left;white-space:normal;font-size:1em} .btn-acc:focus {color: #0056b3!important;} <\/style>\n<p><script>\ndocument.getElementsByClassName(\"elementor-element-df2f370\")[0].style.display = \"none\";\n<\/script><\/p>\n","protected":false},"featured_media":25034,"template":"","format":[4853],"old-keyword":[],"topic":[3939,3979,3980,3978,3982],"serie":[4242],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Sesi\u00f3n m\u00e9dica | Congreso Mundial FMH 2022 - eLearning Platform<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sesi\u00f3n m\u00e9dica | Congreso Mundial FMH 2022 - eLearning Platform\" \/>\n<meta property=\"og:description\" content=\"En estas sesiones del Congreso Mundial 2022 de la FMH, escuche Radek Kaczmarek, Johnny Mahlangu, Steve Pipe, K. Rajender Reddy, Pratima Chowdary, Angela Weyand, Johnny Mahlangu, Gili Kenet y Amy Shapiro abordar temas m\u00e9dicos actuales en trastornos de la coagulaci\u00f3n. La FMH no se compromete en la pr\u00e1ctica de la medicina y en ning\u00fan caso [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"eLearning Platform\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-13T16:40:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/elearning.wfh.org\/wp-content\/uploads\/2022\/11\/Congress-medical-thumbnail-ES.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/\",\"url\":\"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/\",\"name\":\"Sesi\u00f3n m\u00e9dica | Congreso Mundial FMH 2022 - eLearning Platform\",\"isPartOf\":{\"@id\":\"https:\/\/elearning.wfh.org\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/elearning.wfh.org\/wp-content\/uploads\/2022\/11\/Congress-medical-thumbnail-ES.png\",\"datePublished\":\"2022-11-07T16:18:10+00:00\",\"dateModified\":\"2024-11-13T16:40:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/#primaryimage\",\"url\":\"https:\/\/elearning.wfh.org\/wp-content\/uploads\/2022\/11\/Congress-medical-thumbnail-ES.png\",\"contentUrl\":\"https:\/\/elearning.wfh.org\/wp-content\/uploads\/2022\/11\/Congress-medical-thumbnail-ES.png\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Resources\",\"item\":\"https:\/\/elearning.wfh.org\/es\/resource\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sesi\u00f3n m\u00e9dica | Congreso Mundial FMH 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/elearning.wfh.org\/es\/#website\",\"url\":\"https:\/\/elearning.wfh.org\/es\/\",\"name\":\"eLearning Platform\",\"description\":\"World Federation of Hemophilia\",\"publisher\":{\"@id\":\"https:\/\/elearning.wfh.org\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/elearning.wfh.org\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/elearning.wfh.org\/es\/#organization\",\"name\":\"eLearning Platform\",\"url\":\"https:\/\/elearning.wfh.org\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/elearning.wfh.org\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/elearning.wfh.org\/wp-content\/uploads\/2022\/06\/WFH-eLearning-Logo-RGB.png\",\"contentUrl\":\"https:\/\/elearning.wfh.org\/wp-content\/uploads\/2022\/06\/WFH-eLearning-Logo-RGB.png\",\"width\":1460,\"height\":418,\"caption\":\"eLearning Platform\"},\"image\":{\"@id\":\"https:\/\/elearning.wfh.org\/es\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sesi\u00f3n m\u00e9dica | Congreso Mundial FMH 2022 - eLearning Platform","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/","og_locale":"es_ES","og_type":"article","og_title":"Sesi\u00f3n m\u00e9dica | Congreso Mundial FMH 2022 - eLearning Platform","og_description":"En estas sesiones del Congreso Mundial 2022 de la FMH, escuche Radek Kaczmarek, Johnny Mahlangu, Steve Pipe, K. Rajender Reddy, Pratima Chowdary, Angela Weyand, Johnny Mahlangu, Gili Kenet y Amy Shapiro abordar temas m\u00e9dicos actuales en trastornos de la coagulaci\u00f3n. La FMH no se compromete en la pr\u00e1ctica de la medicina y en ning\u00fan caso [&hellip;]","og_url":"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/","og_site_name":"eLearning Platform","article_modified_time":"2024-11-13T16:40:07+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/elearning.wfh.org\/wp-content\/uploads\/2022\/11\/Congress-medical-thumbnail-ES.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/","url":"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/","name":"Sesi\u00f3n m\u00e9dica | Congreso Mundial FMH 2022 - eLearning Platform","isPartOf":{"@id":"https:\/\/elearning.wfh.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/#primaryimage"},"image":{"@id":"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/elearning.wfh.org\/wp-content\/uploads\/2022\/11\/Congress-medical-thumbnail-ES.png","datePublished":"2022-11-07T16:18:10+00:00","dateModified":"2024-11-13T16:40:07+00:00","breadcrumb":{"@id":"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/#primaryimage","url":"https:\/\/elearning.wfh.org\/wp-content\/uploads\/2022\/11\/Congress-medical-thumbnail-ES.png","contentUrl":"https:\/\/elearning.wfh.org\/wp-content\/uploads\/2022\/11\/Congress-medical-thumbnail-ES.png","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/elearning.wfh.org\/es\/resource\/sesion-medica-congreso-mundial-fmh-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Resources","item":"https:\/\/elearning.wfh.org\/es\/resource\/"},{"@type":"ListItem","position":2,"name":"Sesi\u00f3n m\u00e9dica | Congreso Mundial FMH 2022"}]},{"@type":"WebSite","@id":"https:\/\/elearning.wfh.org\/es\/#website","url":"https:\/\/elearning.wfh.org\/es\/","name":"eLearning Platform","description":"World Federation of Hemophilia","publisher":{"@id":"https:\/\/elearning.wfh.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/elearning.wfh.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/elearning.wfh.org\/es\/#organization","name":"eLearning Platform","url":"https:\/\/elearning.wfh.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/elearning.wfh.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/elearning.wfh.org\/wp-content\/uploads\/2022\/06\/WFH-eLearning-Logo-RGB.png","contentUrl":"https:\/\/elearning.wfh.org\/wp-content\/uploads\/2022\/06\/WFH-eLearning-Logo-RGB.png","width":1460,"height":418,"caption":"eLearning Platform"},"image":{"@id":"https:\/\/elearning.wfh.org\/es\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/elearning.wfh.org\/es\/wp-json\/wp\/v2\/resource\/24550"}],"collection":[{"href":"https:\/\/elearning.wfh.org\/es\/wp-json\/wp\/v2\/resource"}],"about":[{"href":"https:\/\/elearning.wfh.org\/es\/wp-json\/wp\/v2\/types\/resource"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/elearning.wfh.org\/es\/wp-json\/wp\/v2\/media\/25034"}],"wp:attachment":[{"href":"https:\/\/elearning.wfh.org\/es\/wp-json\/wp\/v2\/media?parent=24550"}],"wp:term":[{"taxonomy":"old-keyword","embeddable":true,"href":"https:\/\/elearning.wfh.org\/es\/wp-json\/wp\/v2\/old-keyword?post=24550"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/elearning.wfh.org\/es\/wp-json\/wp\/v2\/topic?post=24550"},{"taxonomy":"format","embeddable":true,"href":"https:\/\/elearning.wfh.org\/es\/wp-json\/wp\/v2\/format?post=24550"},{"taxonomy":"serie","embeddable":true,"href":"https:\/\/elearning.wfh.org\/es\/wp-json\/wp\/v2\/serie?post=24550"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}